TriangleStudy of B7-H3-Specific CAR T Cell… (NCT04185038)
Study of B7-H3-Specific CAR T Cell Locore… trial for Central Nervous System Tumor (NCT04185038). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
Diffuse midline glioma grows in a child's brainstem, where no surgeon can cut. Radiation buys time; half of these children live under a year.
The idea: teach the child's own immune cells to find the tumor, and deliver them straight into the brain.
T cells from the child's blood are fitted with a receptor for B7-H3, a marker most of these tumors carry. Then, instead of a vein, they go through a small catheter into the fluid around the brain, dose after dose, over months.
In the first twenty-one children, repeated doses were tolerable, and three were alive more than three and a half years after diagnosis.
BrainChild-03, at Seattle Children's, now asks the same question in more tumors. Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.